wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48371625-56EA6694-48A7-4BC4-8A9A-D438561D425B
Q48371625-56EA6694-48A7-4BC4-8A9A-D438561D425B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48371625-56EA6694-48A7-4BC4-8A9A-D438561D425B
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
P2860
Q48371625-56EA6694-48A7-4BC4-8A9A-D438561D425B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48371625-56EA6694-48A7-4BC4-8A9A-D438561D425B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
46a8d07f795e29e010405174e95208813295ee50
P2860
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer.